🇺🇸 FDA
Patent

US 8211447

Recombinant P. falciparum merozoite protein-142 vaccine

granted A61KA61K39/00A61K39/015

Quick answer

US patent 8211447 (Recombinant P. falciparum merozoite protein-142 vaccine) held by The United States of America as represented by the Secretary of the Army expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Jul 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K39/00, A61K39/015, A61P, A61P31/04